NYSEMKT: PHGE
Biomx Inc Stock Ownership - Who owns Biomx?

Insider buying vs selling

Have Biomx Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James E. FlynnDirector2025-02-27353,249$0.93
$328.87kBuy
James E. FlynnDirector2025-02-27353,249$0.93
$328.87kBuy

1 of 1

PHGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHGE insiders and whales buy or sell their stock.

PHGE Shareholders

What type of owners hold Biomx Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Israel Biofund GP Limited Partnership52.62%13,773,653$5.72MInsider
Erez Chimovits17.68%4,626,978$1.92MInsider
Chidozie Ugwumba11.45%2,997,025$1.24MInsider
James E. Flynn9.53%2,494,108$1.04MInsider
Deerfield Management Company LP Series C9.53%2,494,108$1.04MInstitution
Nantahala Capital Management LLC9.53%2,493,309$1.03MInstitution
Takeda Pharmaceutical Co Ltd9.44%2,470,935$1.03MInsider
Jonas Grossman7.95%2,080,217$863.29kInsider
Orbimed Advisors LLC6.83%1,787,767$741.92kInstitution
Fibrosis Foundation Cystic6.83%1,787,758$741.92kInsider

1 of 3

PHGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHGE30.12%69.88%Net Buying
CVM26.72%73.28%Net BuyingNet Buying
LIXT5.17%94.83%
NXTC52.31%47.69%
PHIO0.10%99.90%Net BuyingNet Buying

Biomx Stock Ownership FAQ

Who owns Biomx?

Biomx (NYSEMKT: PHGE) is owned by 51.18% institutional shareholders, 118.77% Biomx insiders, and 0.00% retail investors. Orbimed Israel Biofund GP Limited Partnership is the largest individual Biomx shareholder, owning 13.77M shares representing 52.62% of the company. Orbimed Israel Biofund GP Limited Partnership's Biomx shares are currently valued at $5.72M.

If you're new to stock investing, here's how to buy Biomx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.